QT Imaging (NASDAQ:QTI) Issues Earnings Results

QT Imaging (NASDAQ:QTI – Get Free Report) announced its earnings results on Tuesday. The company reported ($0.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.05), Zacks reports. QT Imaging had a negative return on equity of 1,202.69% and a negative net margin of 77.25%.

Here are the key takeaways from QT Imaging’s conference call:

  • Third-quarter revenue rose 75% year over year to $7.3 million, with 15 scanners sold versus nine a year earlier; nine-month revenue nearly doubled to $21.3 million.
  • CMS established separate Medicare hospital outpatient payment for medically necessary diagnostic QTscan exams, effective January 1, 2027, building on a dedicated billing code. The coverage applies to diagnostic exams, not routine screening, and broader payer adoption remains a goal.
  • A Premier purchasing agreement gives participating providers access to QT Imaging’s scanners across nearly 4,400 hospitals and health systems, while the company’s new facility has doubled manufacturing capacity. Management says converting this expanded reach into orders and installations is now the priority.
  • QT Imaging lowered its 2026 revenue outlook to approximately $34 million from $39 million, citing Middle East shipping disruptions affecting expected Saudi Arabia and UAE shipments; timing for those deliveries remains uncertain, while the U.S. shipment plan is unchanged.
  • Operating expenses rose to $5.5 million and operating loss widened to $2.4 million. Cash used in operations was $10.7 million in the first nine months, with $8.4 million in cash, cash equivalents, and restricted cash at quarter-end; the reported $297,000 quarterly net loss included a $2.4 million non-cash gain tied to the earnout liability.

QT Imaging Stock Performance

Shares of QT Imaging stock traded down $0.03 during midday trading on Tuesday, hitting $2.26. The company had a trading volume of 60,460 shares, compared to its average volume of 41,266. QT Imaging has a 12-month low of $2.01 and a 12-month high of $7.60. The company has a fifty day simple moving average of $2.48 and a 200 day simple moving average of $4.36. The company has a quick ratio of 2.06, a current ratio of 3.10 and a debt-to-equity ratio of 6.81. The stock has a market cap of $31.12 million, a price-to-earnings ratio of -1.44 and a beta of 0.05.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on QTI. Craig Hallum began coverage on shares of QT Imaging in a report on Monday, October 5th. They issued a “buy” rating and a $8.00 price target on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of QT Imaging in a report on Tuesday, October 6th. Finally, D. Boral Capital began coverage on QT Imaging in a research report on Friday, October 23rd. They issued a “buy” rating and a $9.00 price objective for the company. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $8.50.

Check Out Our Latest Stock Analysis on QTI

About QT Imaging

(Get Free Report)

QT Imaging Holdings, Inc. (NASDAQ:QTI) is a medical technology company that develops advanced ultrasound-based imaging systems. Its technology is designed to create three-dimensional images of human tissue without using ionizing radiation. The company’s principal product is the QTscan, an automated breast-imaging system that uses sound waves to capture images without breast compression. The system is intended to support breast imaging and may be particularly relevant for evaluating breast tissue that can be difficult to assess with conventional mammography.

Read More

Earnings History for QT Imaging (NASDAQ:QTI)

Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.